This article from the June 2016 issue of the European Respiratory Journal was published with an incorrect version of figure 1, in which the key was mislabelled: the solid black line should have identified anticoagulant (AC) nonusers and the dashed line AC users. The corrected figure is reproduced below, and the article has been corrected and republished online.
FIGURE 1
Unadjusted 1-year risk of a) all-cause and b) idiopathic pulmonary fibrosis-related mortality: baseline anticoagulant (AC) users and nonusers. p-values based on the log-rank test: a) p = 0.030 and b) p = 0.0011.
- Copyright ©ERS 2016
Vol 48 Issue 2
Table of Contents
“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784.
